Congenital Heart Disease News and Research RSS Feed - Congenital Heart Disease News and Research

New potential therapeutic targets for treatment of pulmonary arterial hypertension

New potential therapeutic targets for treatment of pulmonary arterial hypertension

Two new potential therapeutic targets for the treatment of pulmonary arterial hypertension, a deadly disease marked by high blood pressure in the lungs, have been identified by researchers at the University of Illinois at Chicago. [More]
Novel document on ventricular arrhythmias published in EP Europace

Novel document on ventricular arrhythmias published in EP Europace

The first expert consensus on ventricular arrhythmias is published today. The novel document compiles current evidence on the diagnosis and management of ventricular arrhythmias and was agreed by international experts from three continents. [More]
CHOP launches Fetal Neuroprotection and Neuroplasticity Program

CHOP launches Fetal Neuroprotection and Neuroplasticity Program

The Children's Hospital of Philadelphia today launched the Fetal Neuroprotection and Neuroplasticity Program. Building on growing evidence of the interaction of heart disease and brain development in the fetus, this Program will systematically investigate innovative therapies to protect brain development and to prevent brain injury as early as possible before birth. [More]
Study measures radiation exposure for children with heart disease

Study measures radiation exposure for children with heart disease

Complex heart imaging can increase cancer risks for children throughout their lifetime, according to a new study co-authored by Le Bonheur Cardiologist Jason Johnson, MD, MHS. The study, which appears in the June 9, 2014 issue of the American Heart Association's journal Circulation, is the first in which researchers quantified cumulative radiation doses in pediatric heart patients and predicted lifetime cancer risks based on the types of exposures. [More]
‘Real-world’ ambrisentan data unveiled

‘Real-world’ ambrisentan data unveiled

The use of and outcomes with ambrisentan in clinical practice are different to those in clinical trials, reflecting different patient characteristics in the “real world”, say researchers. [More]
Prevalence of pulmonary arterial hypertension characterised in CHD patients

Prevalence of pulmonary arterial hypertension characterised in CHD patients

Pulmonary arterial hypertension affects just over 3% of individuals with congenital heart disease, reveal nationwide data from the Netherlands. [More]
LUMEDX, Scientific Software Solutions to create Comprehensive Congenital Cardiac Information System

LUMEDX, Scientific Software Solutions to create Comprehensive Congenital Cardiac Information System

LUMEDX Corporation, a leading provider of cloud-based cardiovascular imaging and information systems (CVIS), and Scientific Software Solutions, Inc., (SSS), maker of PedCath congenital catheterization (cath) reporting software, announced today that they are partnering to create an innovative solution for congenital cardiac data and image management. [More]
Mortality after cardiac surgery: an interview with Dr. Bryan G. Maxwell, Johns Hopkins Medicine

Mortality after cardiac surgery: an interview with Dr. Bryan G. Maxwell, Johns Hopkins Medicine

The last decade has seen a strong movement towards the use of various quality measurements to grade medical care. In surgery, 30-day mortality is one of the most common benchmarks. We wanted to determine if patterns of postoperative mortality showed any signs that the process of measuring medical care might actually alter how (and when) care is provided or withdrawn. [More]
Loyola offers new type of implantable defibrillator that prevents sudden cardiac death

Loyola offers new type of implantable defibrillator that prevents sudden cardiac death

Loyola University Medical Center has begun offering patients a new type of implantable defibrillator that prevents sudden cardiac death with an electric shock to the heart. [More]
Fibroblasts could offer alternative to heart transplants for patients with heart disease

Fibroblasts could offer alternative to heart transplants for patients with heart disease

Fibroblasts, cells long thought to be boring and irrelevant, could offer an alternative to heart transplants for patients with heart disease. [More]
Endogenous tissue growth: an interview with Laurent Grandidier, CEO, Xeltis

Endogenous tissue growth: an interview with Laurent Grandidier, CEO, Xeltis

ETG or Endogenous Tissue Growth is a new therapeutic category in which surgeons use implants designed to allow the body to repair itself by spontaneously growing natural, healthy tissue from the inside without the use of stem cells or animal-derived products. [More]
More compassion, resources required to help guide treatment choices for congenital heart disease

More compassion, resources required to help guide treatment choices for congenital heart disease

Based on a survey of parents of children with congenital heart disease, physicians delivering the diagnosis need to do a better job of showing compassion, ensuring parents understand all their options and providing easily understandable information, according to a new study published in the February edition of the journal, Pediatric Cardiology. [More]
Elsevier launches medical reference and learning platforms for clinicians, students

Elsevier launches medical reference and learning platforms for clinicians, students

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of the fully redesigned Expert Consult and Student Consult, its two medical reference and learning platforms, now powered by Inkling, the creator of engaging, intuitive digital books for some of the world's most respected publishers. [More]
Waiting room time helps in effective screening for depression and anxiety

Waiting room time helps in effective screening for depression and anxiety

A new study in General Hospital Psychiatry finds patients visiting the hospital for a variety of ailments can be easily screened for depression and anxiety as they wait for care, information that can then be sent immediately to their doctor to address. [More]
Costs of care differ significantly across hospitals for children born with heart defects

Costs of care differ significantly across hospitals for children born with heart defects

Costs of care differ significantly across hospitals for children born with heart defects, according to new research led by a University of Michigan researcher. Congenital heart defects are known to be the most common birth defects, impacting nearly 1 in every 100 births. [More]
Researchers find new drug compound that treats laboratory mice with congenital heart disease

Researchers find new drug compound that treats laboratory mice with congenital heart disease

Congenital heart disease is the most common form of birth defect, affecting one out of every 125 babies, according to the National Institutes of Health. Researchers from the University of Missouri recently found success using a drug to treat laboratory mice with one form of congenital heart disease, hypertrophic cardiomyopathy - a weakening of the heart caused by abnormally thick muscle. [More]
Admedus obtains FDA clearance to market CardioCel in the US

Admedus obtains FDA clearance to market CardioCel in the US

Admedus today announced it has received FDA clearance to market CardioCel in the US. CardioCel is the group's lead regenerative tissue product to repair and treat a range of cardiovascular and vascular defects. The Company will now look to complement its existing product launch in Europe with preparation for initial sales in the US. [More]
Special publication details breakthrough research on causes of vascular disease

Special publication details breakthrough research on causes of vascular disease

The world's leading voices in the fight against Pulmonary Hypertension have compiled a special publication detailing the breakthrough research into the causes of this debilitating vascular disease. [More]
Further boost for copy number variant role in schizophrenia

Further boost for copy number variant role in schizophrenia

A large study confirms that 11 previously identified copy number variants are likely associated with schizophrenia. [More]
Copenhagen scientists study link between congenital arrhythmia and hypoglycemia

Copenhagen scientists study link between congenital arrhythmia and hypoglycemia

In a new study, scientists from University of Copenhagen document a connection between congenital arrhythmia and the bodies' ability to handle sugar. The results can be of vital importance for patients with the disease and for the future treatment of diabetes. The new study has just been published in the scientific journal Diabetes. [More]